Effect of parathyroidectomy on subclinical cardiovascular disease in mild primary hyperparathyroidism

European Journal of Endocrinology

Volumn 167, Issue 2, 2012, Pages 277-285

  Walker, M D ^a   Rundek, T ^b   Homma, S ^a   DiTullio, M ^a   Iwata, S ^a   Lee, J A ^a   Choi, J ^a   Liu, R ^a   Zhang, C ^a   McMahon, D J ^a   Sacco, R L ^b   Silverberg, S J ^a,b  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTERIAL STIFFNESS; ARTERY INTIMA PROLIFERATION; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PARAMETERS; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; CLINICAL ARTICLE; COHORT ANALYSIS; DIASTOLIC DYSFUNCTION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART CALCIFICATION; HEART LEFT VENTRICLE MASS; HUMAN; ISOVOLUMIC RELAXATION TIME; MALE; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; TISSUE DOPPLER PEAK EARLY DIASTOLIC VELOCITY; TREATMENT RESPONSE; ULTRASOUND; VALVULAR CALCIFICATION;

AGED; ASYMPTOMATIC DISEASES; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; COHORT STUDIES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED; PARATHYROIDECTOMY; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84864362604     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0124     Document Type: Article

References (55)

1. Hedback G, Oden A & Tisell LE. The influence of surgery on the risk of death in patients with primary hyperparathyroidism. World Journal of Surgery 1991 15 399-405 (discussion 406-397). (doi:10.1007/BF01658740)
2. Palmer M, Adami HO, Bergstrom R, Akerstrom G & Ljunghall S. Mortality after surgery for primary hyperparathyroidism: a follow-up of 441 patients operated on from 1956 to 1979. Surgery 1987 102 1-7.
3. Silverberg SJ, Shane E, Jacobs TP, Siris E & Bilezikian JP. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. New England Journal of Medicine 1999 341 1249-1255. (doi:10.1056/NEJM199910213411701)
4. Wermers RA, Khosla S, Atkinson EJ, Grant CS, Hodgson SF, O'Fallon WM & Melton LJ III. Survival after the diagnosis of hyperparathyroidism: a population-based study. American Journal of Medicine 1998 104 115-122. (doi:10.1016/S0002-9343(97)00270-2)
5. Yu N, Donnan PT & Leese GP. A record linkage study of outcomes in patients with mild primary hyperparathyroidism: the Parathyroid Epidemiology and Audit Research Study (PEARS). Clinical Endocrinology 2010 75 169-176. (doi:10.1111/j.1365-2265. 2010.03958.x)
6. Walker MD, Fleischer J, Rundek T, McMahon DJ, Homma S, Sacco R & Silverberg SJ. Carotid vascular abnormalities in primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2009 94 3849-3856. (doi:10.1210/jc.2009-1086)
7. Walker MD, Fleischer JB, Di Tullio MR, Homma S, Rundek T, Stein EM, Zhang C, Taggart T, McMahon DJ & Silverberg SJ. Cardiac structure and diastolic function in mild primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2010 95 2172-2179. (doi:10.1210/jc.2009-2072)
8. Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M & Rubin MR. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. Journal of Clinical Endocrinology and Metabolism 2009 94 351-365. (doi:10.1210/jc. 2008-1760)
9. Iwata I, Walker MD, Di Tullio MR, Hyodo E, Jin Z, Liu R, Sacco RL, Homma S & Silverberg SJ. Aortic valve calcification in mild primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2011 97 132-137. (doi:10.1210/jc.2011-2107)
10. Dalberg K, Brodin LA, Juhlin-Dannfelt A & Farnebo LO. Cardiac function in primary hyperparathyroidism before and after operation. An echocardiographic study. European Journal of Surgery 1996 162 171-176.
11. Nappi S, Saha H, Virtanen V, Limnell V, Sand J, Salmi J & Pasternack A. Left ventricular structure and function in primary hyperparathyroidism before and after parathyroidectomy. Cardiology 2000 93 229-233. (doi:10.1159/ 000007031)
12. Piovesan A, Molineri N, Casasso F, Emmolo I, Ugliengo G, Cesario F & Borretta G. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clinical Endocrinology 1999 50 321-328. (doi:10.1046/j.1365-2265. 1999.00651.x)
13. Stefenelli T, Abela C, Frank H, Koller-Strametz J, Globits S, Bergler-Klein J & Niederle B. Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up. Journal of Clinical Endocrinology and Metabolism 1997 82 106-112. (doi:10.1210/jc.82.1.106)
14. Farahnak P, Ring M, Caidahl K, Farnebo LO, Eriksson MJ & Nilsson IL. Cardiac function in mild primary hyperparathyroidism and the outcome after parathyroidectomy. European Journal of Endocrinology 2010 163 461-467. (doi:10.1530/EJE-10-0201)
15. Persson A, Bollerslev J, Rosen T, Mollerup CL, Franco C, Isaksen GA, Ueland T, Jansson S & Caidahl K. Effect of surgery on cardiac structure and function in mild primary hyperparathyroidism. Clinical Endocrinology 2011 74 174-180. (doi:10.1111/j. 1365-2265.2010.03909.x)
16. Levy D, Garrison RJ, Savage DD, Kannel WB & Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. New England Journal of Medicine 1990 322 1561-1566. (doi:10.1056/ NEJM199005313222203)
17. Gardin JM, McClelland R, Kitzman D, Lima JA, Bommer W, Klopfenstein HS, Wong ND, Smith VE & Gottdiener J. M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study). American Journal of Cardiology 2001 87 1051-1057. (doi:10.1016/S0002-9149(01) 01460-6)
18. Mogelvang R, Sogaard P, Pedersen SA, Olsen NT, Marott JL, Schnohr P, Goetze JP & Jensen JS. Cardiac dysfunction assessed by echocardiographic tissue Doppler imaging is an independent predictor of mortality in the general population. Circulation 2009 119 2679-2685. (doi:10.1161/CIRCULATIONAHA.108. 793471)
19. Kohsaka S, Jin Z, Rundek T, Boden-Albala B, Homma S, Sacco RL & Di Tullio MR. Impact of mitral annular calcification on cardiovascular events in a multiethnic community: the Northern Manhattan Study. JACC Cardiovascular Imaging 2008 1 617-623. (doi:10.1016/j.jcmg.2008.07.006)
20. Chambless LE, Folsom AR, Clegg LX, Sharrett AR, Shahar E, Nieto FJ, Rosamond WD & Evans G. Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. American Journal of Epidemiology 2000 151 478-487. (doi:10.1093/oxfordjournals.aje. a010233)
21. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL & Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. New England Journal of Medicine 1999 340 14-22. (doi:10.1056/ NEJM199901073400103)
22. Tsivgoulis G, Vemmos K, Papamichael C, Spengos K, Daffertshofer M, Cimboneriu A, Zis V, Lekakis J, Zakopoulos N & Mavrikakis M. Common carotid arterial stiffness and the risk of ischaemic stroke. European Journal of Neurology 2006 13 475-481. (doi:10.1111/j.1468-1331.2006.01291.x)
23. Polak JF, Shemanski L, O'Leary DH, Lefkowitz D, Price TR, Savage PJ, Brant WE & Reid C. Hypoechoic plaque at US of the carotid artery: an independent risk factor for incident stroke in adults aged 65 years or older. Cardiovascular Health Study. Radiology 1998 208 649-654.
24. Rundek T, Arif H, Boden-Albala B, Elkind MS, Paik MC & Sacco RL. Carotid plaque, a subclinical precursor of vascular events: the Northern Manhattan Study. Neurology 2008 70 1200-1207. (doi:10.1212/01.wnl.0000303969. 63165.34)
25. Friedewald WT, Levy RI & Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 1972 18 499-502.
26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419. (doi:10.1007/ BF00280883)
27. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N & Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of Internal Medicine 1999 130 461-470.
28. Rundek T, Elkind MS, Pittman J, Boden-Albala B, Martin S, Humphries SE, Juo SH & Sacco RL. Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: the Northern Manhattan Prospective Cohort Study. Stroke 2002 33 1420-1423. (doi:10.1161/01.STR. 0000015558.63492.B6)
29. Juo SH, Lin HF, Rundek T, Sabala EA, Boden-Albala B, Park N, Lan MY & Sacco RL. Genetic and environmental contributions to carotid intima-media thickness and obesity phenotypes in the Northern Manhattan Family Study. Stroke 2004 35 2243-2247. (doi:10.1161/01.STR.0000142132.20442.d8)
30. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS & Stewart WJ. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. Journal of the American Society of Echocardiography 2005 18 1440-1463. (doi:10.1016/j.echo.2005.10.005)
31. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I & Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. American Journal of Cardiology 1986 57 450-458. (doi:10.1016/0002-9149(86) 90771-X)
32. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA & Evangelisa A. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. European Journal of Echocardiography 2009 10 165-193. (doi:10.1093/ ejechocard/jep007)
33. Cohn JN. Arterial stiffness, vascular disease, and risk of cardiovascular events. Circulation 2006 113 601-603. (doi:10.1161/ CIRCULATIONAHA.105.600866)
34. Dolan E, Thijs L, Li Y, Atkins N, McCormack P, McClory S, O'Brien E, Staessen JA & Stanton AV. Ambulatory arterial stiffness index as a predictor of cardiovascular mortality in the Dublin Outcome Study. Hypertension 2006 47 365-370. (doi:10.1161/01.HYP.0000200699.74641.c5)
35. Benetos A, Thomas F, Joly L, Blacher J, Pannier B, Labat C, Salvi P, Smulyan H & Safar ME. Pulse pressure amplification a mechanical biomarker of cardiovascular risk. Journal of the American College of Cardiology 2010 55 1032-1037. (doi:10.1016/j.jacc.2009.09. 061)
36. Schillaci G, Pucci G, Pirro M, Monacelli M, Scarponi AM, Manfredelli MR, Rondelli F, Avenia N & Mannarino E. Largeartery stiffness: a reversible marker of cardiovascular risk in primary hyperparathyroidism. Atherosclerosis 2011 218 96-101. (doi:10.1016/j.atherosclerosis.2011.05.010)
37. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME & London GM. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001 103 987-992. (doi:10.1161/01.CIR.103.7.987)
38. Rubin MR, Maurer MS, McMahon DJ, Bilezikian JP & Silverberg SJ. Arterial stiffness in mild primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2005 90 3326-3330. (doi:10.1210/jc.2004-1400)
39. Smith JC, Page MD, John R, Wheeler MH, Cockcroft JR, Scanlon MF & Davies JS. Augmentation of central arterial pressure in mild primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2000 85 3515-3519. (doi:10.1210/jc. 85.10.3515)
40. Rambausek M, Ritz E, Rascher W, Kreusser W, Mann JF, Kreye VA & Mehls O. Vascular effects of parathyroid hormone (PTH). Advances in Experimental Medicine and Biology 1982 151 619-632.
41. Hulter HN, Melby JC, Peterson JC & Cooke CR. Chronic continuous PTH infusion results in hypertension in normal subjects. Journal of Clinical Hypertension 1986 2 360-370.
42. Stefenelli T, Mayr H, Bergler-Klein J, Globits S, Woloszczuk W & Niederle B. Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. American Journal of Medicine 1993 95 197-202. (doi:10.1016/0002-9343(93)90260-V)
43. Cosmi JE, Kort S, Tunick PA, Rosenzweig BP, Freedberg RS, Katz ES, Applebaum RM & Kronzon I. The risk of the development of aortic stenosis in patients with "benign" aortic valve thickening. Archives of Internal Medicine 2002 162 2345-2347. (doi:10.1001/ archinte.162.20.2345)
44. Silverberg SJ, Gartenberg F, Jacobs TP, Shane E, Siris E, Staron RB, McMahon DJ & Bilezikian JP. Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 1995 80 729-734. (doi:10.1210/jc.80.3.729)
45. Nakaoka D, Sugimoto T, Kobayashi T, Yamaguchi T, Kobayashi A & Chihara K. Prediction of bone mass change after parathyroidectomy in patients with primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2000 85 1901-1907. (doi:10.1210/jc.85.5.1901)
46. Bots ML, Palmer MK, Dogan S, Plantinga Y, Raichlen JS, Evans GW, O'Leary DH, Grobbee DE & Crouse JR III. Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study. Journal of Internal Medicine 2009 265 698-707. (doi:10.1111/j.1365- 2796.2009.02073.x)
47. Crouse JR III, Byington RP, Bond MG, Espeland MA, Craven TE, Sprinkle JW, McGovern ME & Furberg CD. Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II). American Journal of Cardiology 1995 75 455-459. (doi:10.1016/S0002- 9149(99)80580-3)
48. Riccioni G, Vitulano N, Mancini B, Zanasi A & D'Orazio N. Oneyear treatment with rosuvastatin reduces intima-media thickness in 45 hypercholesterolemic subjects with asymptomatic carotid artery disease. Pharmacology 2010 85 63-67. (doi:10.1159/ 000276476)
49. Lunder M, Janic M, Jug B & Sabovic M. The effects of low-dose fluvastatin and valsartan combination on arterial function: a randomized clinical trial. European Journal of Internal Medicine 2012 23 261-266. (doi:10.1016/j.ejim.2011.11.011)
50. Mizuguchi Y, Oishi Y, Miyoshi H, Iuchi A, Nagase N & Oki T. Impact of statin therapy on left ventricular function and carotid arterial stiffness in patients with hypercholesterolemia. Circulation Journal 2008 72 538-544. (doi:10.1253/circj.72.538)
51. Ratchford EV, Gutierrez J, Lorenzo D, McClendon MS, Della-Morte D, DeRosa JT, Elkind MS, Sacco RL & Rundek T. Short-term effect of atorvastatin on carotid artery elasticity: a pilot study. Stroke 2011 42 3460-3464. (doi:10.1161/STROKEAHA. 111.625418)
52. Bolland MJ, Grey AB, Gamble GD & Reid IR. Association between primary hyperparathyroidism and increased body weight: a metaanalysis. Journal of Clinical Endocrinology and Metabolism 2005 90 1525-1530. (doi:10.1210/jc.2004- 1891)
53. Ayturk S, Gursoy A, Bascil Tutuncu N, Ertugrul DT & Guvener Demirag N. Changes in insulin sensitivity and glucose and bone metabolism over time in patients with asymptomatic primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2006 91 4260-4263. (doi:10.1210/jc.2005-2825)
54. Bollerslev J, Rosen T, Mollerup CL, Nordenstrom J, Baranowski M, Franco C, Pernow Y, Isaksen GA, Godang K, Ueland T & Jansson S. Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2009 94 2255-2261. (doi:10.1210/jc.2008- 2742)
55. Bilezikian JP, Khan AA & Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. Journal of Clinical Endocrinology and Metabolism 2009 94 335-339. (doi:10.1210/jc.2008-1763)